IMU is "NOT " a muli bagger, page-20

So bottom line is not many believe IMU management anymore except few insiders who knows when to sell and buy at bottom. This is a sinking ship and now I started to believe that this is more than a lifestyle shares for the management at the cost of retail holders.

In last 3 years IMU has not progressed anywhere towards commercialisation of any drugs, neither they have come close to treatment of any cancer. PD1 is archived, Azer-Cel is bought with manufacturing facility but manufacturing is sold. Rather than focusing on specific cancer type they have put hand everywhere without any credibility. Now the next data release will be make or break for the company.

If you look at its IPO price of 20C($12.5M) its P is -75% at today, however its MC is significantly grown. LC is claiming they can get $2.5B revenue/year, however Mr market thinks tells another story. In last 2 months it has lost 60% of its value and still trending down. I wish I have never touched IMU